These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 1422868)

  • 1. [Contribution of a hematologic cytogenetic laboratory to the diagnosis, classification and prognosis of various hematologic malignancies].
    Debray J; Krulik M; Smadja NV
    Bull Acad Natl Med; 1992 May; 176(5):629-38; discussion 638-40. PubMed ID: 1422868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetics in the diagnosis of hematologic malignancies.
    Clare N; Hansen K
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):785-807. PubMed ID: 7961291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytogenetic analysis in 941 consecutive patients with haematologic disorders.
    Billström R; Nilsson PG; Mitelman F
    Scand J Haematol; 1986 Jul; 37(1):29-40. PubMed ID: 3464085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic and prognostic value of chromosome studies in cancer.
    Nowell PC
    Ann Clin Lab Sci; 1974; 4(4):234-40. PubMed ID: 4533399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cytogenetic studies in hematological diseases. Analysis of 185 cases].
    Porto B; Mota A; Coutinho J; Justiça B; Malheiro MI
    Sangre (Barc); 1993 Apr; 38(2):103-14. PubMed ID: 8516724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proposals for standardized protocols for cytogenetic analyses of acute leukemias, chronic lymphocytic leukemia, chronic myeloid leukemia, chronic myeloproliferative disorders, and myelodysplastic syndromes.
    Haferlach C; Rieder H; Lillington DM; Dastugue N; Hagemeijer A; Harbott J; Stilgenbauer S; Knuutila S; Johansson B; Fonatsch C
    Genes Chromosomes Cancer; 2007 May; 46(5):494-9. PubMed ID: 17311250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cytogenetics and clinical studies of hematologic malignancies with 11q23 abnormalities in China].
    Guo Y; Xue Y; Xie X; Wu D; Li J; Lu D; Jiang F; Geng M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2000 Apr; 17(2):72-5. PubMed ID: 10751523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular genetic analysis of haematological malignancies: I. Acute leukaemias and myeloproliferative disorders.
    Bench AJ; Erber WN; Scott MA
    Clin Lab Haematol; 2005 Jun; 27(3):148-71. PubMed ID: 15938721
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conventional cytogenetics of myeloproliferative diseases other than CML contribute valid information.
    Bacher U; Haferlach T; Kern W; Hiddemann W; Schnittger S; Schoch C
    Ann Hematol; 2005 Apr; 84(4):250-7. PubMed ID: 15692838
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physician Education: Myelodysplastic Syndrome.
    Yoshida Y
    Oncologist; 1996; 1(4):284-287. PubMed ID: 10388004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical importance of karyotype in hematology].
    Bellomo MJ
    Schweiz Med Wochenschr; 1994 Jan; 124(1-2):26-36. PubMed ID: 8296188
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimising therapy in patients with haematological malignancies].
    Dumontet C
    Bull Cancer; 2008 Oct; 95(10):959-62. PubMed ID: 19004726
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Prognostic value of bone marrow biopsy in chronic myeloproliferative disorders].
    Bettini R; Marzetta K; Miglioranza A; Redaelli S; Maino C; Maffiolini A; Gorini M
    Recenti Prog Med; 2003; 94(7-8):314-20. PubMed ID: 12868237
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases.
    Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M
    Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic significance of del(20q) in patients with hematological malignancies.
    Brezinová J; Zemanová Z; Ransdorfová S; Sindelárová L; Sisková M; Neuwirtová R; Cermák J; Michalová K
    Cancer Genet Cytogenet; 2005 Jul; 160(2):188-92. PubMed ID: 15993278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia?
    Larson RA
    Best Pract Res Clin Haematol; 2007 Mar; 20(1):29-37. PubMed ID: 17336252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical significance of Y chromosome loss in hematologic disease.
    Wiktor A; Rybicki BA; Piao ZS; Shurafa M; Barthel B; Maeda K; Van Dyke DL
    Genes Chromosomes Cancer; 2000 Jan; 27(1):11-6. PubMed ID: 10564581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective application of a multiplex reverse transcription-polymerase chain reaction assay for the detection of balanced translocations in leukaemia: a single-laboratory study of 390 paediatric and adult patients.
    Olesen LH; Clausen N; Dimitrijevic A; Kerndrup G; Kjeldsen E; Hokland P
    Br J Haematol; 2004 Oct; 127(1):59-66. PubMed ID: 15384978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis of myeloid hematologic malignancies: contributions of the 2001 World Health Organization (WHO) classification].
    Leymarie V; Galoisy AC; Falkenrodt A; Lessard M
    Ann Biol Clin (Paris); 2004; 62(5):513-20. PubMed ID: 15355801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.